Literature DB >> 18629390

Endoscopist-administered propofol: a retrospective safety study.

John W I Morse1, Sharyle A Fowler, Amy L Morse.   

Abstract

BACKGROUND: Propofol is an anesthetic agent that is commonly used for conscious sedation. Propofol has advantages as a sedative agent for endoscopic procedures including rapid onset, short half-life and rapid recovery time. However, concerns exist regarding the potential for respiratory depression, hypotension, perforation due to deep sedation and the need for monitoring by an anesthetist. Propofol has been used under endoscopist supervision at the Stanton Territorial Hospital in Yellowknife, Northwest Territories since 1996 (approximately 7000 cases).
METHODS: A retrospective chart review of endoscopic procedures conducted at the Stanton Territorial Hospital between January 1996 and May 2007 was performed. A random sample of 680 procedures was reviewed from a total of 6396 procedures.
RESULTS: The mean (+/- SD) baseline systolic blood pressure (SBP) was 122.8+/-17.0 mmHg. The mean lowest SBP was 101.7+/-14.5 mmHg. The mean absolute drop in SBP was 21.1+/-16.7 mmHg, with a mean per cent drop of 16.3%+/-11.7%. Eighty-eight patients (12.9%) developed transient hypotension (SBP lower than 90 mmHg). All patients regained normal blood pressure spontaneously on repeated measurement. No patients required intravenous fluid resuscitation. The mean O2 saturation was 96.4%+/-2.1%. One patient (0.1%) transiently desaturated (O2 saturation 89%), but recovered spontaneously on repeat measurement with no intervention. No procedures were aborted for patient safety. There were no major complications, including perforation or death. There was one mucosal tear during nontherapeutic colonoscopy (0.1%).
CONCLUSIONS: Propofol can be safely administered in a community hospital setting under endoscopist supervision, with no additional support or monitoring.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18629390      PMCID: PMC2661266          DOI: 10.1155/2008/265465

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  10 in total

1.  Propofol for endoscopy in Canada: a sleepy or a slippery slope? Dr Rakesh Bhandari is interviewed by Paul C Adams.

Authors:  Rakesh Bhandari
Journal:  Can J Gastroenterol       Date:  2006-12       Impact factor: 3.522

Review 2.  AGA Institute review of endoscopic sedation.

Authors:  Lawrence B Cohen; Mark H Delegge; James Aisenberg; Joel V Brill; John M Inadomi; Michael L Kochman; Joseph D Piorkowski
Journal:  Gastroenterology       Date:  2007-08       Impact factor: 22.682

3.  Propofol sedation during endoscopic procedures: safe and effective administration by registered nurses supervised by endoscopists.

Authors:  G Tohda; S Higashi; S Wakahara; M Morikawa; H Sakumoto; T Kane
Journal:  Endoscopy       Date:  2006-04       Impact factor: 10.093

4.  Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis.

Authors:  Mohammed A Qadeer; John J Vargo; Farah Khandwala; Rocio Lopez; Gregory Zuccaro
Journal:  Clin Gastroenterol Hepatol       Date:  2005-11       Impact factor: 11.382

5.  Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy.

Authors:  Douglas K Rex; Ludwig T Heuss; John A Walker; Rong Qi
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

6.  Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases.

Authors:  Ludwig T Heuss; Patrizia Schnieper; Juergen Drewe; Eric Pflimlin; Christoph Beglinger
Journal:  Gastrointest Endosc       Date:  2003-05       Impact factor: 9.427

7.  Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients.

Authors:  Ian F Yusoff; Ginette Raymond; Anand V Sahai
Journal:  Gastrointest Endosc       Date:  2004-09       Impact factor: 9.427

8.  Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial.

Authors:  John J Vargo; Gregory Zuccaro; John A Dumot; Kenneth M Shermock; J Brad Morrow; Darwin L Conwell; Patricia A Trolli; Walter G Maurer
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

9.  Endoscopic perforation rates at a Canadian university teaching hospital.

Authors:  Tarun Misra; Eoin Lalor; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2004-04       Impact factor: 3.522

10.  Propofol use for sedation during endoscopy in adults: a Canadian Association of Gastroenterology position statement.

Authors:  Michael F Byrne; Naoki Chiba; Harminder Singh; Daniel C Sadowski
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

  10 in total
  4 in total

Review 1.  Endoscopist-directed propofol: pros and cons.

Authors:  Eun Hye Kim; Sang Kil Lee
Journal:  Clin Endosc       Date:  2014-03-31

2.  How does tolerability of double balloon enteroscopy compare to other forms of endoscopy?

Authors:  Andrew J Irvine; David S Sanders; Andrew Hopper; Matthew Kurien; Reena Sidhu
Journal:  Frontline Gastroenterol       Date:  2015-03-18

3.  Propofol versus Midazolam for Sedation during Esophagogastroduodenoscopy in Children.

Authors:  Ji Eun Oh; Hae Jeong Lee; Young Hwan Lee
Journal:  Clin Endosc       Date:  2013-07-31

4.  Morbidity and mortality of endoscopist-directed nurse-administered propofol sedation (EDNAPS) in a tertiary referral center.

Authors:  Marie Ooi; Andrew Thomson
Journal:  Endosc Int Open       Date:  2015-08-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.